SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-081604
Filing Date
2024-07-03
Accepted
2024-07-03 17:00:05
Documents
1
Period of Report
2024-07-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3741
  Complete submission text file 0000950170-24-081604.txt   5281
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Issuer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 5150 EL CAMINO REAL, SUITE #A-32 LOS ALTOS CA 94022
Business Address
Jayasuriya Anula (Reporting) CIK: 0001822933 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12830 | Film No.: 241100786